VenoStent raises $2.2 million to begin clinical trials Feb 22 Written by Health Wildcatters Health Wildcatters Previous Previous VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients Next Next Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment
VenoStent raises $2.2 million to begin clinical trials Feb 22 Written by Health Wildcatters Health Wildcatters